TickerFacts.

Beta Bionics, Inc. (BBNX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$287.61M
As of 2025-12-31
$256.37M
As of 2026-06-30
2023-12-31: -$203.10M2024-12-31: -$245.36M2025-12-31: $287.61M$287.61M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$287.61Mn/m2026-02-24, Balance as of period end
2024-12-31-$245.36Mn/m2026-02-24, Balance as of period end
2023-12-31-$203.10Mn/a2025-03-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Beta Bionics, Inc. (BBNX)2025-12-31$287.61Mn/m
NeuroPace Inc (NPCE)2025-12-31$19.03M+137.5%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$259.66M+26.4%
Pulmonx Corp (LUNG)2025-12-31$54.12M-36.9%
Anika Therapeutics, Inc. (ANIK)2025-12-31$143.47M-6.8%
Orasure Technologies Inc (OSUR)2025-12-31$340.83M-16.9%
Delcath Systems, Inc. (DCTH)2025-12-31$111.22M+61.8%
Iradimed Corp (IRMD)2025-12-31$94.62M+9.0%
TELA Bio, Inc. (TELA)2025-12-31$6.31M-77.8%

Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗